Literature DB >> 5299888

The immune response to influenza virus. II. Effect of the route and schedule of vaccination on the quantity and avidity of antibodies.

R G Webster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5299888      PMCID: PMC1409247     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  9 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

2.  VARIATIONS IN THE IMMUNE RESPONSE TO A SIMPLE DETERMINANT.

Authors:  L A STEINER; H N EISEN
Journal:  Trans Assoc Am Physicians       Date:  1964

3.  Avidity and inter cellular transfer of hemolysin.

Authors:  W H TALIAFERRO; L G TALIAFERRO; A K PIZZI
Journal:  J Infect Dis       Date:  1959 Nov-Dec       Impact factor: 5.226

4.  The dissociation of hemolytic antibody from sensitized cells as measured by cell-to-cell transfer.

Authors:  H S GOODMAN; L MASAITIS
Journal:  J Immunol       Date:  1960-10       Impact factor: 5.422

5.  The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation.

Authors:  N K JERNE; P AVEGNO
Journal:  J Immunol       Date:  1956-03       Impact factor: 5.422

6.  The immune response to influenza virus. 3. Changes in the avidity and specificity of early IgM and IgG antibodies.

Authors:  R G Webster
Journal:  Immunology       Date:  1968-01       Impact factor: 7.397

7.  The immune response to influenza virus. I. Effect of the route and schedule of vaccination on the time course of the immune response, as measured by three serological methods.

Authors:  R G Webster
Journal:  Immunology       Date:  1965-12       Impact factor: 7.397

8.  Antibody formation. V. The avidity of gamma-M and gamma-G guinea pig antibodies to bacteriophage phi-x 174.

Authors:  M S Finkelstein; J W Uhr
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

9.  Disquisitions of Original Antigenic Sin. I. Evidence in man.

Authors:  R G Webster
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

  9 in total
  7 in total

1.  Evolutionary changes in influenza B are not primarily governed by antibody selection.

Authors:  G M Air; A J Gibbs; W G Laver; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  The immune response to influenza virus. 3. Changes in the avidity and specificity of early IgM and IgG antibodies.

Authors:  R G Webster
Journal:  Immunology       Date:  1968-01       Impact factor: 7.397

3.  The relative antigen-neutralizing capacity (avidity) of thyroglobulin antibodies in various thyroid diseases as measured by haemagglutination-inhibition with antibody-coated cells.

Authors:  T Hjort
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

4.  Role of natural killer cells in Pichinde virus infection of Syrian hamsters.

Authors:  S R Gee; M A Chan; D A Clark; W E Rawls
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

5.  Mumps class-specific immunoglobulins in radioimmunoassay and conventional serology.

Authors:  H Daugharty; D T Warfield; W D Hemingway; H L Casey
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

6.  A study of the specificities of sequential antisera to variola and monkeypox viruses by radioimmunoassay.

Authors:  H H Walls; D W Ziegler; J H Nakano
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

7.  Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope.

Authors:  Adva Mechaly; Eran Diamant; Ron Alcalay; Alon Ben David; Eyal Dor; Amram Torgeman; Ada Barnea; Meni Girshengorn; Lilach Levin; Eyal Epstein; Ariel Tennenhouse; Sarel J Fleishman; Ran Zichel; Ohad Mazor
Journal:  Antibodies (Basel)       Date:  2022-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.